Chronic Inflammatory Demyelinating Polyneuropathy: Immunopathological and Ultrastructural Study of Peripheral Nerve Biopsy in 42 Cases

References

• Dyck PJ, O´Brien PC, Oviatt KF, et al. Prednisone improves chronic inflammatory demyelinating polyradiculoneuropathy more than no treatment. Ann Neurol. 1982; 11: 136–141.
   Google Scholar
• Pollard JD, McLeod JG, Gatenby P, Kronenberg H. Prediction of response to plasma exchange in chronic relapsing polyneuropathy: a clinico- pathological correlation. J Neurol Sci. 1983; 58: 269–287.
   Google Scholar
• Hugues RAC. Guillain-Barre Syndrome. London: Springer; 1990.
   Google Scholar
• Dyck PJ, Prineas J, Pollard J. Chronic inflammatory demyelinating polyradiculoneuropathy. In: Dyck PJ, Thomas PK, eds. Peripheral Neuropathy, Vol 2, ed 3. Philadelphia: Saunders; 1993:1498–1517.
   Google Scholar
• Hartung HP, van der Meche´ FGA, Pollard JD. Guillain-Barre´ syndrome, CIDP and other chronic immune- mediated neuropathies. Curr Opin Neurol. 1998;11:497–513.
   PubMed Web of Science ®Google Scholar
• Dalakas MC. Advances in chronic inflammatory demyelinating polyneuropathy: disease variants and inflammatory response mediators and modifers. Curr Opin Neurol. 1999;12:403–409.
   PubMedGoogle Scholar
• Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barre´ polyneuropathy. Brain. 1986;109:1115–1126.
   PubMed Web of Science ®Google Scholar
• Feasby TE, Hahn AF, Brown WF, Bolton CF, Gilbert JJ, Koopman WF. Severe axonal degeneration in acute Guillain-Barre´ syndrome: evidence of two different mechanisms? J Neurol Sci. 1993;116:185–192.
   Google Scholar
• Griffn JW, Li CY, Ho TW, et al. Pathology of the motor- sensory axonal Guillain-Barre´ syndrome. Ann Neurol. 1996;39:17–28.
   PubMedGoogle Scholar
• Julien J, Vital C, Lagueny A, Ferrer X, Brechenmacher C. Chronic relapsing idiopathic polyneuropathy with primary axonal lesions. J Neurol Neurosurg Psychiatr. 1989;52:871–875.
   PubMed Web of Science ®Google Scholar
• Chroni E, Hall SM, Hughes RAC. Chronic relapsing axonal neuropathy: a frst case report. Ann Neurol. 1995;37:112–115.
   PubMed Web of Science ®Google Scholar
• Uncini A, Sabatelli M, Mignogna T, Lugaresi A, Liguori R, Montagna P. Chronic progressive steroid responsive axonal polyneuropathy: a CIDP variant or a primary axonal disorder? Muscle Nerve. 1996;19:365–371.
   Google Scholar
• Schmidt B, Toyka KV, Kiefer R, Full J, Hartung HP, Pollard J. Inflammatory infltrates in sural nerve biopsies in Guillain-Barre´ syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve. 1996;19:474–487.
   PubMed Web of Science ®Google Scholar
• Kiefer R, Kieseier BC, BrÏ ck W, Hartung HP, Toyka KV. Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies. Brain. 1998;121:469–479.
   PubMed Web of Science ®Google Scholar
• Rizzuto N, Morbin M, Cavallaro T, Ferrari S, Fallahi M, Galiazzo- Rizzuto S. Focal lesions area feature of chronic inflammatory demyelinating polyneuropathy (CIDP). Acta Neuropathol. 1998;96:603–609.
   PubMed Web of Science ®Google Scholar
• Kanda T, Yamawaki M, Iwasaki T, Mizusawa H. Glycosphingolipid antibodies and blood-nerve barrier in autoimmune demyelinative neuropathy. Neurology. 2000; 54: 1459–1464.
   Google Scholar
• Vital A, Vital C, Brechenmacher C, Fontan D, Castaing Y. Chronic inflammatory demyelinating polyneuropathy in childhood: ultrastructural features of peripheral nerve biopsies in four cases. Eur J Pediatr. 1990;149:654–658.
   PubMedGoogle Scholar
• Vital C, Vital A, Lagueny A, Larribau E, Saintarailles J, Julien J. Subacute inflammatory polyneuropathy: two cases with plasmacytoid histiocytes in the endoneurium. Ultrastruct Pathol. 1998; 22: 377–383.
   Google Scholar
• Gorson KC, Allam G, Ropper AH. Chronic inflammatory demyelinating polyneuropathy: clinical features and response to treatment in 67 consecutive patients with and without a monoclonal gammopathy. Neurology. 1997;48:321–328.
   PubMed Web of Science ®Google Scholar
• Barnett MH, Pollard JD, Davies L, McLeod J G. Cyclosporin A in resistant chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 1998;21:454–460.
   PubMed Web of Science ®Google Scholar
• Vital A, Lagueny A, Julien J, et al. Chronic inflammatory demyelinating polyneuropathy associated with dysglobulinemia: a peripheral nerve biopsy study in 18 cases. Acta Neuropathol. 2000; 100: 63–68.
   Google Scholar
• Gorson KC, Ropper AH, Adelman LS, Weinberg DH. Influence of diabetes mellitus on chronic inflammatory demyelinating polyneuropathy. Muscle Nerve. 2000;23:37–43.
   PubMed Web of Science ®Google Scholar
• Ferrer X, Vital C, Larrivie`re M, Richard S, J ulien J. Idiopathic CD4‡ T- cell lymphocytopenia and subacute inflammatory demyelinating polyradiculoneuropathy. Neurology. 1995; 45: 196–197.
   Google Scholar
• Vital A, Fontan D, Petry KG, Lagueny A, Pillet P, Vital C. Serum immunoglobulin. A defciency in relapsing inflammatory demyelinating polyneuropathy. Muscle Nerve. 1999;22:543–545.
   PubMedGoogle Scholar
• Berger JR, Gallo B. Chronic inflammatory polyradiculoneuropathy associated with alopecia universalis. Muscle Nerve. 1998;21:124–125.
   PubMedGoogle Scholar
• Gabree«ls- Festen AAWM, Gabree«ls FJM, Hoogendijk JE, Bolhuis PA, J ongen PJH, Vingerhoets HM. Chronic inflammatory demyelinating polyneuropathy or hereditary motor and sensory neuropathy? Diagnostic value of morphological criteria. Acta Neuropathol. 1993;86:630–635.
   PubMedGoogle Scholar
• Matsumuro K, Izumo S, Umehara F, Osame M. Chronic inflammatory demyelinating polyneuropathy: histological and immunopathological studies on biopsied sural nerves. J Neurol Sci. 1994; 127:170-178.Bouchard C, Lacroix C, Plante´ V, et al. Clinicopathologic fndings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology. 1999;52:498–503.
   PubMedGoogle Scholar
• Lampert PW. Mechanism of demyelination in experimental allergic neuritis. Lab Invest. 1969;20:127–138.
   PubMed Web of Science ®Google Scholar
• Prineas JW. Pathology of the Guillain-Barre´ syndrome. Ann Neurol. 1981;9(Suppl):6-19.
   Google Scholar
• Brechenmacher C, Vital C, Deminie`re C, et al. Guillain-Barre´ syndrome: an ultrastructural study of peripheral nerve in 65 patients. Clin Neuropathol. 1987;6:19–24.
   PubMed Web of Science ®Google Scholar
• Vital C, Vallat JM. Ultrastructural Study of the Human Diseased Peripheral Nerve, ed 2. New York: Elsevier; 987:1–290.
   Google Scholar
• Midroni G, Bilbao JM. Biopsy Diagnosis of Peripheral Neuropathy. Boston: Butterworth-Heinemann; 1995:1–477.
   Google Scholar
• King RHM. Atlas of Peripheral Nerve Pathology. London: Arnold; 1999:1–217.
   Google Scholar
• Prineas JW. Demyelination and remyelination in recurrent idiopathic polyneuropathy: an electron- microscope study. Acta Neuropathol. 1971;18:34–57.
   PubMed Web of Science ®Google Scholar
• Duggins AJ, McLeod JG, Pollard JD, et al. Spinal root and plexus hypertrophy in chronic inflammatory demyelinating polyneuropathy. Brain. 1999;122:1383–1390.
   PubMed Web of Science ®Google Scholar
• Hattori N, Ichimura M, Aoki S, et al. Clinicopathological features of chronic inflammatory demyelinating polyradiculoneuropathy in childhood. J Neurol Sci. 1998;154:66–71.
   PubMedGoogle Scholar
• Vital A, Barat M, Lagueny A, Latour P, Vital C. Asymmetrical polyneuropathy with a stepwise progressive course and well- demarcated areas of demyelination. Muscle Nerve. 1999; 22: 1139–1145.
   Google Scholar
• Ingall TJ, McLeod JG, Tamura N. Autonomic function and unmyelinated fbers in chronic inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve. 1990;13:70–76.
   PubMedGoogle Scholar
• Brechenmacher C, Vital C, Laurentjoye L, Castaing Y. Ultrastructural study of peripheral nerve in Guillain-Barre´ syndrome. Presence of mononuclear cells in axons. Acta Neuropathol. 1981;Suppl VII:249-251.
   Google Scholar
• Lu JL, Sheikh KA, Wu HS, et al. Physiologic-pathologic correlation in Guillain-Barre´ syndrome in children. Neurology. 2000;54:33–39.
   PubMed Web of Science ®Google Scholar
• Hadden RDM, Cornblath DR, Hughes RAC, et al. Electrophysiological classifcation of Guillain-Barre´ syndrome: clinical associations and outcome. Ann Neurol. 1998; 44: 780–788.
   Google Scholar
• Hahn AF, Bolton CF, Pillay N, et al. Plasma- exchange therapy in chronic inflammatory demyelinating polyneuropathy: a double- blind, sham- controlled, cross- over study. Brain. 1996; 119: 1055–1066.
   Google Scholar
• Hahn AF, Bolton CF, Zochodne D, Feasby TE. Intravenous immunoglobulin treatment in chronic inflammatory demyelinating polyneuropathy: a double- blind, placebo- controlled, cross- over study. Brain. 1996; 119: 1067–1077.
   Google Scholar
• Mathey EK, Pollard JD, Armati PJ. TNFa, IFNg and IL- 2 mRNA expression in CIDP sural nerve biopsies. J Neurol Sci. 1999; 163: 47–52.
   Google Scholar
• Melendez- Vasquez C, Redford J, Choudhary PP, et al. Immunological investigation of chronic inflammatory demyelinating polyradiculoneuropathy. J Neuroimmunol. 1997; 73: 124–134.
   Google Scholar
• Wan WX, Taylor J, Andrias- Kauba S, Pollard JD. Passive transfer of demyelination by serum or IgG from chronic inflammatory demyelinating polyneuropathy patients. Ann Neurol. 2000; 47: 765–775.
   Google Scholar